“…Neither individual randomized controlled trials of intensive surveillance with colonoscopy 20 nor meta‐analyses of these trials 26 have demonstrated a survival benefit from the original primary tumor by performing colonoscopy at annual or shorter intervals. The failure of surveillance endoscopic exams to improve survival from recurrent colorectal cancer appears to result from relatively low rates of anastomotic or intraluminal recurrence and the observation that anastomotic or intraluminal recurrences are generally associated with intraabdominal or pelvic disease that is unresectable for cure 2–24,26,27 , , , , , , , , , , , , , , , , , , , , , , , , . In summary, performance of annual colonoscopy for the purpose of detecting recurrent disease does not have an established survival benefit for patients with colorectal cancer.…”